Advanced search×

Leech therapy in the treatment of median nerve compression due to forearm haematoma.

M Schenker, A Murray, and S P J Kay

J Neurol Neurosurg Psy... 77(6):799; author reply 799-800 (2006) PMID 16705206 PMCID PMC2077453

Version: za2963e q8za7 q8zbd q8zce q8zd1 q8zeb q8zf3 q8zga
View PDF

Similar articles you may find interesting…

  1. Effect of 1110 MBq Radioiodine in Reducing Thyroid Volume in Multinodular Goiter: A New Protocol.
    Armando Flores-Rebollar, Aida Ruiz-Juvera, and Ofelia Gonzalez-Trevino

    J Clin Med Res 5(3):234-8 (2013) PMID 23671549

    Our study included 5 women with MNG treated with MMI, 10 - 15 mg/day for 2 to 4 months, prior to the administration of 1110 MBq (131)I (30 mCi); none of the patients developed hypothyroidism during MMI therapy and had average basal TSH levels of 0.32 ± 0.39 mIU/L that increased to 2.6 ± 0.9 mIU/L...
    PDF not found
  2. Factors associated with reduced efficacy of sitagliptin therapy: analysis of 93 patients with type 2 diabetes treated for 1.5 years or longe...
    Akira Kanamori and Ikuro Matsuba

    J Clin Med Res 5(3):217-21 (2013) PMID 23671547

    Several studies have shown the effectiveness of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for type 2 diabetes, with a hypoglycemic effect being demonstrated both when it is administered alone or in combination with other oral antidiabetic agents. However, there are few reports...
    PDF not found
  3. Recombinant hormones in osteoporosis.
    Lars Rejnmark

    Expert Opin Biol Ther (2013) PMID 23646915

    For the last 10 years, bone anabolic therapy with the recombinant human parathyroid hormone (rhPTH) analogue, teriparatide (rhPTH[1-34]), or full-length rhPTH(1-84) has been an option in the treatment of osteoporosis. Both drugs are given as a daily subcutaneous injection. In the USA, only teriparat...
    Buy PDF